Please use this identifier to cite or link to this item:
|Title:||Heparanase, hyaluronan, and CD44 in cancers: A breast carcinoma perspective||Authors:||Götte, M.
|Issue Date:||1-Nov-2006||Citation:||Götte, M., Yip, G.W. (2006-11-01). Heparanase, hyaluronan, and CD44 in cancers: A breast carcinoma perspective. Cancer Research 66 (21) : 10233-10237. ScholarBank@NUS Repository. https://doi.org/10.1158/0008-5472.CAN-06-1464||Abstract:||Glycosaminoglycans are major constituents of the cancer cell surface and the tumor stroma. The heparan sulfate degrading enzyme heparanase, hyaluronan, and its receptor CD44 are up-regulated in breast cancer, generating a microenvironment that promotes tumor progression and metastasis. Recent experimental and clinical evidence shows that heparanase, hyaluronan, and CD44 regulate cancer cell proliferation, migration, and invasion, as well as tumor-associated angiogenesis and are correlated with patient survival. These findings suggest that they may be used as prognostic factors and targets for breast cancer treatment. ©2006 American Association for Cancer Research.||Source Title:||Cancer Research||URI:||http://scholarbank.nus.edu.sg/handle/10635/120695||ISSN:||00085472||DOI:||10.1158/0008-5472.CAN-06-1464|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.